After completing this activity, pharmacists should be able to:
- list targeted agents used in the management of common cancers in Australian patients;
- describe the mechanisms of action, adverse effects, and place in treatment of newer agents used in the treatment of cancer
The 2010 Competency Standards addressed by this activity include: 1.3, 4.2, 7.1, 7.2
The 2016 Competency Standards addressed by this activity include: 2.1, 3.1, 3.3, 3.5
Accreditation number: A1807AJP2 Accreditation expires: 1/8/2020
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.